Inactive Instrument

United Cannabis Corporation

CNABQ

US9097471075

United Cannabis Corporation Appoints Brent Reynolds and Dennis Steindler as Chief Medical Advisors

May 08, 2014 at 12:45 pm EDT

United Cannabis Corporation (UCANN) announced the appointment of Drs. Brent Reynolds and Dennis Steindler as Chief Medical Advisors to run and manage Discovery Research & Development for UCANN, focused on exploring the medical applications of cannabinoids.

Latest news about United Cannabis Corporation

UC Colorado Corporation Bankruptcy Case Dismissed	21-01-11	CI
Motion for Case Dismissal Filed for UC Colorado Corporation	20-12-15	CI
Motion for Case Conversion Filed by Blake Street Partners, LLC, ECG SPV Acreage LLC, and L&M Properties and Holdings	20-12-10	CI
Motion for Case Dismissal Filed for UC Colorado Corporation	20-12-10	CI
Second Motion for Exclusivity Period Extension Approved For UC Colorado Corporation	20-11-30	CI
First Motion for Exclusivity Period Extension Approved For UC Colorado Corporation	20-09-01	CI
Final DIP Financing Approved for UC Colorado Corporation	20-09-01	CI
First Motion for Exclusivity Period Extension Filed by UC Colorado Corporation	20-08-14	CI
United Cannabis Corporation Announces Resignation of Chadwick Ruby as Director	20-07-21	CI
Motion for Joint Administration Approved for UC Colorado Corporation	20-06-19	CI
Motion for Joint Administration Filed by UC Colorado Corporation	20-06-04	CI
Motion for Case Dismissal Filed for UC Colorado Corporation	20-05-13	CI
Motion for Joint Administration Filed by UC Colorado Corporation	20-05-07	CI
UC Colorado Corporation Filed for Bankruptcy	20-04-20	CI
United Cannabis Corporation Receives Notice of Allowance for New Patent Covering Methods of Preparing and Using Cannabinoid Formulations	19-12-12	CI
United Cannabis Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-14	CI
United Cannabis Corporation Enters Partnership With The NuAxess 2, Inc. Self-Funded Health Insurance Platform	19-09-26	CI
United Cannabis Corporation Commences Hemp Extraction Operations in Tennessee	19-09-12	CI
United Cannabis Names Gregory Gerdeman as Chief Scientific Officer	19-08-20	CI
United Cannabis Corporation Establishes Distribution Relationship with Cloud 9 Switzerland	19-08-15	CI
United Cannabis Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-14	CI
United Cannabis Corporation Announces Distribution in the Cayman Islands	19-08-07	CI
United Cannabis Corporation Provides Unaudited Preliminary Revenues for the First Six Months of 2019 and for the Year 2019	19-07-18	CI
United Cannabis Corporation Signs an Agreement to Supply CBD Isolate over the Next 100 Weeks to an Unrelated Third Party	19-07-16	CI
United Cannabis Corporation Appoints Clifton Lambreth as the Chief Marketing Officer	19-07-11	CI

Chart United Cannabis Corporation

Duration

Period

More charts

Company Profile

United Cannabis Corporation is engaged in medical spa management business. The Company focuses on providing products, services and intellectual property to the cannabis industry. It owns intellectual property relating to the legalized growth, production, manufacture, marketing, management, utilization and distribution of medical and recreational marijuana and marijuana infused products. The Company focuses on advancing the use of phytocannabinoid therapeutics in medicine through research, product development and education. The Company's ACT Now Program utilizes its Prana Bio Nutrient Medicinals with a Health Insurance Portability and Accountability Act (HIPAA) of 1996 compliant electronic health record (EHR) software that enables physicians to create sequencing charts specific to their patients' medical aliments. The ACT Now EHR software allows for global monitoring, patient management and cannabinoid therapy protocols. It offers consulting and training services.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+32.48%	5.8B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-26.22%	3.92B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+4.73%	3.28B
TASLY PHARMACEUTICAL GROUP CO., LTD	-20.86%	2.77B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.88%	2.26B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+46.64%	1.95B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-16.71%	1.52B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+44.65%	1.49B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-9.60%	1.49B

Alternative Medicine